Eximias' Other Investors

Eximias raised a round of funding on , . Investors include Quaker BioVentures.

Eximias is developing late stage cancer therapeutics. Eximias is now a wholly-owned subsidiary of YM named YM BioSciences USA…

Articles about Eximias' Other Investors: